Immune Checkpoint Inhibitors Summit, Munich 2016

OracleBio will be attending the Annual Immune Checkpoint Inhibitors Europe Summit, which takes place from the 16th to the 18th of November in Munich, Germany.

immune checkpoint inhibitors logo

OracleBio offers a range of digital pathology image analysis services to support pre-clinical and clinical immuno-oncology R&D and have generated data as part of immune checkpoint inhibitor studies. In one recently published study, we performed digital image analysis for quantification of CD8+T-cells in a mouse syngeneic model to demonstrate the potential of a checkpoint inhibitor combination therapy. OracleBio have generated case studies from this research, as well as other immune checkpoint inhibitor studies, and look forward to discussing this in greater detail at ICI Europe 2016.

Returning for the second year, Immune Checkpoint Inhibitors (ICI) Europe 2016 focuses on how to deliver maximum clinical benefit through immune checkpoint monotherapy and combinations. Incorporating insights from industry leaders, the summit will deliver practical learning on what it takes to develop the next generation of ICI drugs, from pathway validation to clinical success. For more information on Immune Checkpoint Inhibitors (ICI) Europe 2016, please click here.

If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak with OracleBio’s Chief Operations Officer John Waller during the conference, please contact us


Society for Immunotherapy of Cancer Conference


OracleBio’s Chief Scientific Officer Lorcan Sherry and Senior Project Manager Mark Anderson will be attending the 31st Annual Meeting of the Society for Immunotherapy of Cancer (SITC). The event will take place from the 9th to the 13th of November in Washington and is known to be one of the top destinations for scientific exchange, education and networking in the cancer immunotherapy community. The conference is expected to bring together more than 2,400 individuals from around the world to discuss the newest science, insights and innovation in the cancer immunotherapy field.

OracleBio is delighted to be exhibiting at the conference and will also be presenting a poster entitled; ‘Immune Cell Spatial Analysis on FoxP3 and CD8 Positive IHC Stained T Cells within the Tumor Microenvironment’. In this study, tumor tissue was immunohistochemically (IHC) dual labelled for FoxP3 (brown nuclear chromogen) and CD8 (red membrane chromogen). High resolution digital images of these samples were then analysed by OracleBio to quantify CD8 and FoxP3 immune cell relationships in terms of cell infiltration and cell-to-cell proximities within the tumor tissue microenvironment.

We will also be at exhibitor booth No. 337 throughout the conference and look forward to meeting you there to discuss how OracleBio can support your immuno-oncology projects using detailed quantitative image analysis.

OracleBio offers a range of digital pathology image analysis services to support pre-clinical and clinical Oncology R&D studies. If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak to Lorcan or Mark during the congress, please contact us.

Mark   Lorcan